The Global Metabolomics Market is expected to reach USD 2,386.4 million, at a CAGR of 14.6%
Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface-based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) — Forecast
This research report segments this Metabolomics Market based on product and service, application, indication, and region.
The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time
Download PDF (Metabolomics Market):
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007
Major Market Drivers in Metabolomics Market:
- Availability of government and private funding
- Increasing pharmaceutical and biotech R&D expenditure
- Technological advancements
- Growing demand for personalized medicine
- Increasing the use of metabolomics in toxicology testing
Key Questions Addressed in the Research Study:
- Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
- How growing demand for personalized medicine and other factors would change the future of the metabolomics market?
Request Research Sample Pages (Metabolomics Market):
https://www.marketsandmarkets.com/requestsampleNew.asp?id=900
Growing Demand for Personalized Medicine Drive the Metabolomics Market
The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time.
Major Key Players in Metabolomics Market;
Prominent players in the global metabolomics market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.),